ADMA Biologics, Inc. (ADMA)

ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	51.35	86.52	51.09	55.92	26.75
Cash & Cash Equivalents	51.35	86.52	51.09	55.92	26.75
Cash Growth	-40.65%	69.36%	-8.64%	109.03%	-0.01%
Receivables	27.42	15.51	28.58	13.24	3.47
Inventory	172.91	163.28	124.72	81.54	53.06
Other Current Assets	5.33	5.1	4.34	3.05	2.53
Total Current Assets	257.01	270.4	208.73	153.74	85.82
Property, Plant & Equipment	63.47	68.75	58.2	45.85	32.99
Goodwill and Intangibles	4.03	4.54	5.26	5.97	6.69
Other Long-Term Assets	4.67	4.77	4.07	2.11	1.6
Total Long-Term Assets	72.17	78.06	67.52	53.93	41.27
Total Assets	329.18	348.46	276.25	207.67	127.09
Accounts Payable	15.66	13.23	12.43	11.07	9.17
Deferred Revenue	1.87	1.98	2.12	2.26	2.4
Current Debt	1.05	0.91	0.59	0.37	0.23
Other Current Liabilities	31.23	23.16	15.24	6.25	2.22
Total Current Liabilities	49.81	39.27	30.38	19.95	14.03
Long-Term Debt	130.59	142.83	94.87	92.97	83.2
Other Long-Term Liabilities	13.58	14.39	9.84	6.51	3.67
Total Long-Term Liabilities	144.17	157.22	104.7	99.48	86.87
Total Liabilities	193.98	196.49	135.08	119.42	100.9
Total Debt	131.64	143.74	95.46	93.33	83.43
Debt Growth	-8.42%	50.58%	2.27%	11.87%	89.16%
Retained Earnings	-506.26	-478.02	-412.11	-340.47	-264.72
Shareholders' Equity	135.21	151.97	141.17	88.25	26.19
Net Cash / Debt	-80.29	-57.22	-44.37	-37.41	-56.68
Net Cash Per Share	-0.36	-0.29	-0.32	-0.43	-1.04
Working Capital	207.21	231.14	178.35	133.79	71.79
Book Value Per Share	0.60	0.77	1.01	1.02	0.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).